| |
|
|
|
|
|
|
|||
|
Blood, 1 November 2005, Vol. 106, No. 9, pp. 3012-3019. Prepublished online as a Blood First Edition Paper on July 19, 2005; DOI 10.1182/blood-2005-01-0433.
HEMATOPOIESIS Soluble factor cross-talk between human bone marrow-derived hematopoietic and mesenchymal cells enhances in vitro CFU-F and CFU-O growth and reveals heterogeneity in the mesenchymal progenitor cell compartmentFrom the Institute of Biomaterials and Biomedical Engineering, Department of Chemical Engineering and Applied Chemistry, Faculty of Dentistry, University of Toronto, Toronto, ON, Canada.
The homeostatic adult bone marrow (BM) is a complex tissue wherein physical and biochemical interactions serve to maintain a balance between the hematopoietic and nonhematopoietic compartments. To focus on soluble factor interactions occurring between mesenchymal and hematopoietic cells, a serum-free adhesion-independent culture system was developed that allows manipulation of the growth of both mesenchymal and hematopoietic human BM-derived progenitors and the balance between these compartments. Factorial experiments demonstrated a role for stem cell factor (SCF) and interleukin 3 (IL-3) in the concomitant growth of hematopoietic (CD45+) and nonhematopoietic (CD45) cells, as well as their derivatives. Kinetic tracking of IL-3
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2005 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||